What is Aviscera Bioscience?
Aviscera Bioscience operates as a key supplier of specialized Adipokines, Myokines, and Cytokines. The company's focus is on advancing research within the critical areas of Metabolic Syndrome and Cardiovascular Diseases. Its role in providing essential reagents underscores its importance in the scientific community's pursuit of understanding and treating these prevalent health challenges.
How much funding has Aviscera Bioscience raised?
Aviscera Bioscience has raised a total of $21K across 1 funding round:
Debt
$21K
Debt (2021): $21K with participation from PPP
What's next for Aviscera Bioscience?
With the recent influx of expansion capital, Aviscera Bioscience is poised for accelerated growth. This strategic financing, occurring at a significant Series B/C stage, suggests a focus on expanding operational capacity, enhancing product development pipelines, and potentially broadening market reach. The company's trajectory indicates a commitment to solidifying its position as a leader in supplying critical research components for metabolic and cardiovascular disease studies.
See full Aviscera Bioscience company page
